Value of magnetic resonance diffusion-weighted imaging for the prediction of radiosensitivity in nasopharyngeal carcinoma

Otolaryngology - Head and Neck Surgery (United States)

Volumn 149, Issue 5, 2013, Pages 707-713

  Hong, Jinsheng ^a   Yao, Yiqi ^b   Zhang, Yu ^a   Tang, Tianlan ^a   Zhang, Hao ^a   Bao, Daoliang ^b   Chen, Yunbin ^b   Pan, Jianji ^a,c  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b Fujian Cancer Hospital   (China)

^c Fujian Provincial Key Laboratory of Translational Cancer Medicine   (China)

Author keywords

apparent diffusion coefficient; diffusion weighted imaging; nasopharyngeal carcinoma; radiosensitivity

Indexed keywords

CISPLATIN; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COHORT ANALYSIS; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; ECHO PLANAR IMAGING; FEMALE; HUMAN; INDUCTION CHEMOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; NASOPHARYNX CARCINOMA; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; PRIMARY TUMOR; RADIATION DOSE; RADIOSENSITIVITY; TREATMENT PLANNING; WORLD HEALTH ORGANIZATION;

APPARENT DIFFUSION COEFFICIENT; DIFFUSION-WEIGHTED IMAGING; NASOPHARYNGEAL CARCINOMA; RADIOSENSITIVITY;

ADOLESCENT; ADULT; AGED; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RADIATION TOLERANCE; RADIOTHERAPY, ADJUVANT; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 84887453767     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599813496537     Document Type: Article

References (20)

1. Lin S, Pan J, Han L, Zhang X, Liao X, Lu JJ. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys. 2009 ; 75: 1071-1078
2. Lai SZ, Li WF, Chen L, et al. How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?. Int J Radiat Oncol Biol Phys. 2011 ; 80: 661-668
3. Maeda M, Maier SE. Usefulness of diffusion-weighted imaging and the apparent diffusion coefficient in the assessment of head and neck tumors. J Neuroradiol. 2008 ; 35: 71-78
4. Namimoto T, Awai K, Nakaura T, Yanaga Y, Hirai T, Yamashita Y. Role of diffusion-weighted imaging in the diagnosis of gynecological diseases. Eur Radiol. 2009 ; 19: 745-760
5. Sugita R, Ito K, Fujita N, Takahashi S. Diffusion-weighted MRI in abdominal oncology: clinical applications. World J Gastroenterol. 2010 ; 16: 832-836
6. Wu LM, Xu JR, Gu HY, et al. Usefulness of diffusion-weighted magnetic resonance imaging in the diagnosis of prostate cancer. Acad Radiol. 2012 ; 19: 1215-1224
7. DeVries AF, Kremser C, Hein PA, et al. Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys. 2003 ; 56: 958-965
8. Mardor Y, Pfeffer R, Spiegelmann R, et al. Early detection of response to radiation therapy in patients with brain malignancies using conventional and high B-value diffusion-weighted magnetic resonance imaging. J Clin Oncol. 2003 ; 21: 1094-1100
9. Higano S, Yun X, Kumabe T, et al. Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology. 2006 ; 241: 839-846
10. Vandecaveye V, Dirix P, De Keyzer F, et al. Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma. Eur Radiol. 2010 ; 20: 1703-1714
11. Hatakenaka M, Nakamura K, Yabuuchi H, et al. Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy. Int J Radiat Oncol Biol Phys. 2011 ; 81: 339-345
12. Chung C, Jalali S, Foltz W, et al. Imaging biomarker dynamics in an intracranial murine glioma study of radiation and antiangiogenic therapy. Int J Radiat Oncol Biol Phys. 2013 ; 85: 805-812
13. Yan S, Yan D, Yang J, et al. Use of diffusion-weighted magnetic resonance imaging in cervical lymph node metastasis from nasopharyngeal carcinoma patients receiving intensity modulated radiation therapy. Chin J Radiol Med Prot. 2011 ; 31: 312-316
14. He X, Zhu X, Huang D, et al. Application of diffusion-weighted MR imaging and 18F-FDG PET/CT to intensity modulated radiotherapy for nasopharyngeal carcinoma. J Oncol. 2008 ; 14: 783-786
15. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol. 2007 ; 188: 1622-1635
16. Sanjeev C, Sungheon K, Lawrence D, et al. Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck. AJR Am J Roentgenol. 2013 ; 200: 35-43
17. Theilmann RJ, Borders R, Trouard TP, et al. Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia. 2004 ; 6: 831-837
18. Moffat BA, Chenevert TL, Lawrence TS, et al. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A. 2005 ; 102: 5524-5529
19. Fu C, Bian D, Liu F, Feng X, Du W, Wang X. The value of diffusion-weighted magnetic resonance imaging in assessing the response of locally advanced cervical cancer to neoadjuvant chemotherapy. Int J Gynecol Cancer. 2012 ; 22: 1037-1043
20. Dzik-Jurasz A, Domenig C, George M, et al. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet. 2002 ; 360: 307-308